Airesis Sa operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Airesis Sa with three other
financial institutions in Europe:
Gimv Investeringsmaatschappij Voor Vlanderen NV
sales of 141.81 million Euros [US$155.49 million]
of which 43%
was Smart Industries),
BB Biotech AG
(150.99 million Swiss Francs [US$156.31 million]
of which 100%
was Investing & Related Activity), and
based in GERMANY
(155.88 million Euros [US$170.92 million]
Airesis Sa reported sales of 152.87 million Swiss Francs (US$158.25 million)
December of 2018.
increase of 9.1%
versus 2017, when the company's sales were 140.10 million Swiss Francs.
This was the third consecutive year of growth at Airesis Sa.
Sales of Corporate and Other saw an increase
that was more than double the company's growth rate: sales were up
37.7% in 2018, from
1.32 million Swiss Francs to 1.82 million Swiss Francs.